Monday, September 10, 2018

Investorideas.com - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $FIRE.V, TSX: $TRST.TO, TSX: $ACB.TO, TSXV: $N.V

Investorideas.com - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $FIRE.V, TSX: $TRST.TO, TSX: $ACB.TO, TSXV: $N.V





Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: TSXV: $FIRE.V,
TSX: $TRST.TO, TSX: $ACB.TO, TSXV: $N.V

Delta, Kelowna, BC –September 10, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site,
www.potcasts.ca  release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:

Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.

Today we will be looking at announcements from The Supreme Cannabis Company, Inc. Trading on
the TSX-Venture as FIRE,
CannTrust Holdings Inc. trading on the TSX as
TRST,
Aurora Cannabis
Inc. trading on the TSX as ACB and the OTCQB as ACBFF and Namaste Technologies
Inc. trading on the TSX-Venture as N.

The Supreme Cannabis Company, Inc. announced
that the Company's wholly owned subsidiary, 7ACRES, has entered into a supply
agreement to provide dried cannabis to Tilray Canada Ltd., a subsidiary of
Tilray Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation,
processing and distribution currently serving tens of thousands of patients in
11 countries spanning 5 continents.  
The value of this initial supply agreement is
estimated to be in excess of C$2 million. 
Dried cannabis provided to Tilray by 7ACRES will be used primarily to
support medical cannabis patients in Canada, including Tilray's robust patient
population.
CannTrust Holdings Inc. ,one of Canada's
leading licensed producers and most trusted brands for medical cannabis, and
Breakthru Beverage Group, the largest Canadian beverage alcohol broker of
premium spirits, wine and beer brands, have announced the execution of a letter
of intent for an exclusive partnership to represent CannTrust's specialty
products to Canadian adult consumers for recreational use.  Breakthru will invest in the establishment of
a cannabis-focused sales brokerage company and develop a route-to-market
platform for CannTrust in Canada, effective when the adult-use recreational market
opens October 17, 2018.   In addition,
Breakthru is aligning as a strategic partner with CannTrust through a company
investment, as it sees the organization as a long-term market share leader. The
transaction remains subject to typical closing conditions, including the
signing of a definitive agreement, completion of due diligence and TSX's
approval of the private placement.
The respective regulatory regimes for
recreational cannabis are in many ways similar to those currently in place for
beverage alcohol across Canada.  Like
Breakthru's leading role representing many of the top suppliers in the beverage
alcohol industry, the sales brokerage operation will work, where permitted by
law, directly with provincial control boards and designated retail outlets
supporting the sales efforts for the CannTrust portfolio of products. 
The cannabis sales brokerage operation will
reside in a newly-formed subsidiary of Breakthru Beverage Group and will be
entirely separate from its beverage alcohol brokerage, Breakthru Beverage
Canada. It will however leverage the company's North American business
insights, strategies, technology and analytic tools to be a differentiator in
the marketplace.
Aurora Cannabis Inc. and ICC Labs Inc.
(TSX-V: ICC) announced today that the companies have entered into a definitive
arrangement agreement pursuant to which Aurora intends to acquire all of the
issued and outstanding common shares of ICC for $1.95 per share (payable in
common shares of Aurora, reflecting an aggregate purchase price of
approximately $290 million. The Transaction has been unanimously approved by
the Board of Directors of each ICC and Aurora.
Led by CEO Alejandro Antalich, a
widely-recognized leader in the South American cannabis market with over 25
years of experience in the pharmaceutical sector, the acquisition of ICC will
establish Aurora as the industry leader in South America, a continent with over
420 million people. ICC presently has over 70% market share in Uruguay, the
first country in the world to legalize cannabis for adult consumer use. In addition,
ICC holds licenses in Colombia for the production of medical cannabis.
The Transaction, once approved, creates a
strong foundation for expansion, and will leverage ICC's first mover advantage
in South America, bringing significant low-cost production capacity, a
well-diversified product portfolio, and extensive distribution channels
throughout South America and internationally.
Through this transaction there are many
benefits to Aurora including:
CBD Rich Production, as Uruguay is the only
country where regulations currently permit the cultivation of CBD-rich hemp on
a commercial scale, allowing licensed producers to grow hemp with THC
concentrations of up to 1%, providing a significant yield advantage over global
competitors. ICC's deep background in pharma and the ability to grow low-cost
CBD-rich hemp at very large scale, positions the companies exceptionally well
to capitalize on global opportunities in the high-growth CBD wellness market.




As well, ICC recently launched its BIDIOL
brand of CBD products, and is developing a broad international distribution
network, including a presales agreement to export product to Mexico, a market
with over 125 million people.
ICC is also progressing well towards the
completion of a state-of-the-art large-scale extraction facility with capacity
to process 150,000 kg of CBD feed per annum. Phase I of the facility is
anticipated to be completed in October 2018, with the full facility online and
operational by late 2018.
Also, ICC's new CBD extraction facility is
strategically located approximately five minutes from the Canelones
international airport and within Uruguay's "Science Park" free trade
zone, exempting facility exports from any applicable local tax on exports and
import
Whereas for ICC the Share Consideration
represents a premium of approximately 34% on the 20 day volume-weighted average
trading price of ICC Shares on the TSX-V for the period ending August 22, 2018,
the last trading day prior to ICC issuing a news release in respect of a media
report speculating as to a potential transaction involving the acquisition of
ICC.
Aurora Shares are listed and posted for
trading on the TSX, which will provide ICC shareholders with potentially
greater liquidity.
Namaste Technologies Inc. announced that the
Company has pre-launched its revolutionary medical cannabis online marketplace
through its wholly-owned subsidiary, CannMart Inc. CannMart is poised to be
Canada's first medical cannabis "sales-only" license under Health
Canada's ACMPR program. The Company has pre-launched CannMart's website,
CannMart.com, which will allow the Company to commence sales immediately after
receiving its license. Receipt of its sales license, coupled with the official
launch of CannMart.com, will represent the most significant achievement in the
Company's history and will be the catalyst for Namaste introducing legal
cannabis sales into its global e-commerce platform.
Namaste reported that it received
communication from Health Canada on September 6th, 2018, and the Company would
like to reaffirm that the application is progressing. CannMart's license, which
is the first of its kind in Canada, will enable Namaste to procure and sell
medical cannabis from both domestic and international Health Canada approved
cultivators, which will be offered in an AI-driven e-commerce marketplace
designed to provide a unique and personalized experience for each patient.
Namaste has secured supply and holds inventory of a carefully curated selection
of high-quality medical cannabis flower and oil.

Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment   

Potcasts is now a certified word mark Trademark on the blockchain through
Cognate, Inc. CM Certification

Investorideas.com podcasts are also available on iTunes,  Spotify,
Google Play Music, Stitcher,  iHeartradio, Spreaker and Tunein.

If you would like to be a guest or sponsor this podcast contact
Investorideas.com


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on
iTunes,  Spotify, Google Play Music,
Stitcher, Spreaker,   YouTube via
Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and  sector trends 
from Investorideas.com with our news alerts , articles ,
podcasts and videos  talking about cannabis,  crypto, 
technology including  AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily
Crypto Corner and Podcast, Play by Play sports and
stock news column,
Investor
Ideas #Potcasts
#Cannabis News
and Stocks on the Move podcast and column, 
Cleantech and Climate Change Podcast and 
the Stock Guru daily podcast on Support and Resistance Trading.


Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info:
http://www.investorideas.com/About/Disclaimer.asp.

Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations
of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp


Follow us on Social Media





Contact Investorideas.com

800-665-0411






Do you trade or invest in Marijuana / Hemp
Stocks?  Check out our stock directory of
publicly traded  CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin  and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing


No comments: